loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Atrasentan, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Atrasentan

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    1. Also known as: 195733-43-8, Atrasentan hcl, Atrasentan (hydrochloride), Atrasentan hydrochloride [usan], Abbot-147627, E4g31x93za
    Molecular Formula
    C29H39ClN2O6
    Molecular Weight
    547.1  g/mol
    InChI Key
    IJFUJIFSUKPWCZ-SQMFDTLJSA-N
    FDA UNII
    E4G31X93ZA
    A pyrrolidine and benzodioxole derivative that acts a RECEPTOR, ENDOTHELIN A antagonist. It has therapeutic potential as an antineoplastic agent and for the treatment of DIABETIC NEPHROPATHIES.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid;hydrochloride
    2.1.2 InChI
    InChI=1S/C29H38N2O6.ClH/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20;/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34);1H/t23-,27-,28+;/m1./s1
    2.1.3 InChI Key
    IJFUJIFSUKPWCZ-SQMFDTLJSA-N
    2.1.4 Canonical SMILES
    CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl
    2.1.5 Isomeric SMILES
    CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4.Cl
    2.2 Other Identifiers
    2.2.1 UNII
    E4G31X93ZA
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (11c)abt-627

    2. 2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic Acid

    3. A 127722

    4. A 127722.5

    5. A 147627

    6. A-127722

    7. A-127722.5

    8. A-147627

    9. A127722

    10. A127722.5

    11. A147627

    12. Abt 627

    13. Abt-627

    14. Abt627

    15. Atrasentan

    16. Xinlay

    2.3.2 Depositor-Supplied Synonyms

    1. 195733-43-8

    2. Atrasentan Hcl

    3. Atrasentan (hydrochloride)

    4. Atrasentan Hydrochloride [usan]

    5. Abbot-147627

    6. E4g31x93za

    7. 3-pyrrolidinecarboxylicacid,4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-,hydrochloride (1:1), (2r,3r,4s)-

    8. 195733-43-8 (hcl)

    9. A-147627.1

    10. Atrasentan Hydrochloride (usan)

    11. Abbott 147627

    12. Unii-e4g31x93za

    13. (2r,3r,4s)-1-((dibutylcarbamoyl)methyl)-2-(p-methoxyphenyl)-4-(3,4-(methylenedioxy)phenyl)-3-pyrrolidinecarboxylic Acid, Monohydrochloride

    14. (2r,3r,4s)-4-(benzo[d][1,3]dioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic Acid Hydrochloride

    15. (2r,3r,4s)-4-(benzo[d][1,3]dioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic Acid Hydrochloride.

    16. A 147627.1

    17. D03009

    18. (2r,3r,4s)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic Acid Hydrochloride

    19. Chembl2106068

    20. Dtxsid20173240

    21. Ex-a4175

    22. Atrasentan Hydrochloride [mi]

    23. Hy-15403a

    24. Mfcd13194884

    25. Cs-1373

    26. Atrasentan Hydrochloride [mart.]

    27. Atrasentan Hydrochloride [who-dd]

    28. Bs-16407

    29. Atrasentan Hydrochloride, >=98% (hplc)

    30. D82853

    31. 733a438

    32. A930316

    33. Abt-627;abt627;abt 627;abbott 147627

    34. Q27276859

    35. (2r,3r,4s)-(+)-2-(4-methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(n,n-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic Acid Hydrochloride Salt

    36. (2r,3r,4s)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic Acid;hydrochloride

    37. (2r,3r,4s)-4-(benzo[d][1,3]dioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylicacidhydrochloride

    38. 3-pyrrolidinecarboxylic Acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, Monohydrochloride, (2r,3r,4s)-

    39. 3-pyrrolidinecarboxylic Acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, Monohydrochloride, (2r-(2.alpha.,3.beta.,4.alpha.))

    40. 3-pyrrolidinecarboxylic Acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, Monohydrochloride, (2r-(2alpha,3beta,4alpha))

    2.4 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 547.1 g/mol
    Molecular Formula C29H39ClN2O6
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count12
    Exact Mass546.2496647 g/mol
    Monoisotopic Mass546.2496647 g/mol
    Topological Polar Surface Area88.5 Ų
    Heavy Atom Count38
    Formal Charge0
    Complexity734
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of nephropathy

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Antineoplastic Agents

    Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

    Endothelin A Receptor Antagonists

    Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN A RECECPTORS. (See all compounds classified as Endothelin A Receptor Antagonists.)

    Post Enquiry
    POST ENQUIRY